On February 24, Gov. Christie delivered his budget address to a joint session of the legislature, officially kicking off negotiations on the state’s FY 2016 budget. The legislature’s focus for the next few months will essentially be on the budget, as it must be passed by July 1.
Earlier this week Superior Court Judge Nelson Johnson released an evidentiary ruling blocking two experts from testifying in the ongoing litigation over Hoffmann-La Roche Ltd.'s acne medication Accutane. The ruling is further evidence that Atlantic County is not the mass tort hellhole it once was.
A lot of ridiculous lawsuits are filed in New Jersey each year, but only one can be crowned NJCJI’s Most Ludicrous Lawsuit of the Year. 2014’s honoree, the woman suing Disney for $250 million because she claims the blockbuster hit Frozen was stolen from her autobiography, was just recently told by the court that she needs to take Queen Elsa’s advice and “let it go.”
A selection of the need-to-know civil justice news for the [...]
On February 18, the New Jersey Supreme Court issued opinions in two cases that had the potential to dramatically re-shape the state’s insurance law. The court resolved both cases on limited grounds that upheld pre-existing expectations while clarifying the law prospectively, as NJCJI urged it to do in an amicus brief. The court also directed the Civil Practice Committee to take up broader policy questions for further study.
A selection of the need-to-know civil justice news for the [...]
For over a century, Americans have relied on the federal Food and Drug Administration (FDA) to regulate the quality and safety of everything from pharmaceutical products and medical devices to the labels on prepared foods. However, there is a growing trend in the courts that would allow lawsuits over these FDA approved items and their labels, effectively subjecting them to ad hoc regulation at the state level via litigation. On February 10, 2015, the New Jersey Civil Justice Institute hosted a panel discussion on this constantly evolving and critically important area of law with former Solicitor General Paul Clement of Bancroft PLLC; Gerald Masoudi of Covington & Burling LLP, who is the former Chief Counsel of the FDA; and Andrew Boczkowski, an Assistant General Counsel at GlaxoSmithKline.
The New Jersey Consumer Fraud Act has been the focus of several news stories this week since a state court judge issued a ruling that will allow a CFA-based lawsuit over “gay conversion therapy” to move forward.
A selection of the need-to-know civil justice news for the [...]
Each quarter, the Judiciary Times publishes statewide and local news [...]
